United States· US:83819-900_89e2c992-9f25-4bd5-b9dd-dcf069ccd9b4
Dermveda ULTRA COLD SORE RELIEF
A medicinal product containing cardiospermum halicacabum flowering top; turmeric, registered in United States by Celcius Corp..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CARDIOSPERMUM HALICACABUM FLOWERING TOP; TURMERIC
- Manufacturer
- Celcius Corp.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1183819-900-02
- ndc11838199000260 mL in 1 JAR (83819-900-02)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bb7575af-6f6d-40d6-8323-d692dea0d444 GET /v1/drugs/bb7575af-6f6d-40d6-8323-d692dea0d444?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "10; 10",
"substance": "CARDIOSPERMUM HALICACABUM FLOWERING TOP; TURMERIC",
"productndc": "83819-900",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "[hp_X]/60mL; [hp_C]/60mL",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about cardiospermum halicacabum flowering top; turmeric.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.